DNM2 and diabetes mellitus: For example, in patients with diabetes, hyperglycemia-induced formation of advanced glycation end products results in an impairment of axonal transport, a reduction in axon caliber, and a reduced capacity for nerve regeneration, which are closely related to the axonal cytoskeletal proteins such as tubulin and NFs.33